
India's retail asset securitisation market sees 6 pc growth in Q1 FY26
This includes both pass-through certificate (PTC) issuances and direct assignment (DA) transactions, according to CareEdge Ratings report.
The volume represents a 6 per cent growth over the same period previous year.
Despite this, the market's stability is a positive sign, driven by strong demand for credit, confidence from investors, and the strategic efforts of originators to diversify their funding sources.
One of the most significant milestones in Q1 FY26 was the completion of India's first residential mortgage-backed securitisation (RMBS) deal, carried out by RMBS Development Company Limited (RDCL).
This deal was also the first securitisation transaction to be executed on the Electronic Book Provider (EBP) platform, which marks a new chapter in India's securitisation market.
This transaction could act as a catalyst for more investors to enter the RMBS sector, potentially boosting innovation and participation in mortgage-backed securities.
The move is expected to create more long-term funding opportunities and allow for better risk transfer.
Looking at the transaction composition in Q1 FY26, there has been a noticeable shift. PTC transactions now make up 56 per cent of the total volume, which marks a significant change from previous periods when direct assignment (DA) transactions were more dominant.
The increase in PTCs likely reflects changing preferences among investors, regulatory factors, and a growing desire for more standardised and tradable financial products.
This shift also suggests that originators are looking to attract a broader investor base.
Among the PTC issuances, asset-backed securitisation (ABS) products were a major contributor, accounting for around 75 per cent of the total volume.
Mortgage-backed securitisation (MBS), on the other hand, remained steady at 10 per cent. A key highlight in Q1 FY26 was the rise in PTC issuances from Microfinance Institutions (MFIs).
MFIs contributed 15 per cent of the total PTC volumes, a significant increase from 8 per cent in Q1 FY25.
This growth reflects greater stability in asset quality within the microfinance sector, and suggests that investor confidence in this space is on the rise.
In the ABS category, vehicle loan financing continued to be a major player, contributing over Rs 14,600 crore, or 51 per cent of total PTC issuances in Q1 FY26.
This includes loans backed by a variety of vehicles such as commercial trucks, passenger cars, two-wheelers, and construction equipment, the report said.
However, the share of vehicle loans has decreased compared to previous quarters, as other asset classes like unsecured personal loans, business loans, and gold loans gained popularity.
Unsecured loans alone accounted for 15 per cent of total PTC issuances -- indicating a growing interest from investors in these alternative retail credit segments.
In the DA segment, mortgage-backed transactions continued to dominate, making up 67 per cent of the total DA volumes in FY25.
Asset-backed DA transactions accounted for 26 per cent, the report stated.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Standard
22 minutes ago
- Business Standard
Anthem Biosciences IPO subscribed 63.86 times
The offer received bids for 281.44 crore shares as against 4.40 crore shares on offer. The initial public offer of Anthem Biosciences received bids for 2,81,44,34,740 shares as against 4,40,70,682 shares on offer, according to stock exchange data at 17:30 IST on Wednesday (16 July 2025). The issue was subscribed 63.86 times. The issue opened for bidding on 14 July 2025 and it will close on 16 July 2025. The price band of the IPO is fixed between Rs 540 and 570 per share. An investor can bid for a minimum of 26 equity shares and in multiples thereof. The IPO is a full offer for sale of 5,95,61,404 equity shares at the upper price, amounting to Rs 3,395 crore. The company will not receive any funds from the offer; all proceeds will go to the selling shareholders based on the shares they offered. The promoters and promoter group hold a total of 43,17,47,949 equity shares, making up 76.87% of the pre-offer issued and paid-up equity share capital. Their shareholding after the IPO is expected to be around 74.69%. Anthem Biosciences is a tech-oriented CRDMO, providing drug discovery and manufacturing services, as well as specialty ingredients like probiotics, enzymes, and peptides. In FY25, CRDMO contributed 81.65% of its revenue. It serves over 550 clients in more than 44 countries, with Europe and North America being key markets. Supported by green chemistry and a partnership with Davos Pharma in the U.S., the company is growing its capacity and working on technologies like RNAi and ADCs. Ahead of the IPO, Anthem Biosciences on Friday, 11 July 2025, raised Rs 1,016.02 crore from anchor investors. The board allotted 1.78 crore shares at Rs 570 each to 60 anchor investors. The firm reported a consolidated net profit of Rs 451.26 crore and sales of Rs 1,844.55 crore for the twelve months ended on 31 March 2025.


Deccan Herald
22 minutes ago
- Deccan Herald
This monsoon, PM Modi to rain freebies for poll-bound Bihar
During his 53rd visit to the State as PM, and second within a month, Modi will launch projects worth Rs 7,200 crore.


Time of India
34 minutes ago
- Time of India
360 ONE Overnight Fund collects Rs 200 crore during NFO period
360 ONE Mutual Fund has announced the successful close of the New Fund Offer (NFO) for its newly launched 360 ONE Overnight Fund , having garnered over Rs 200 crore during the subscription period. The new fund offer or NFO of the fund was open from July 1 to July 9. The open-ended debt scheme, which invests in overnight securities, received interest from a wide base of investors, including corporates, HNIs, and individual investors looking for efficient short-term deployment of surplus funds. Also Read | HDFC Defence Fund picks up smallcap stock that surged 300% in 3 years Best MF to invest Looking for the best mutual funds to invest? Here are our recommendations. View Details » by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Gold Is Surging in 2025 — Smart Traders Are Already In IC Markets Learn More Undo According to the fund house, the encouraging response reflects investor preference for low-risk, high-liquidity solutions. The fund reopened for continuous sale and repurchase from July 14, with no exit load and a minimum investment amount of Rs 5,000 (and in multiples of Re 1 thereafter). Live Events 'We are pleased with the encouraging investor response to the 360 ONE Overnight Fund. This validates the market's appetite for simple, low-risk, and liquid investment avenues—especially in uncertain or transitional market phases. Our commitment remains to offer intelligent solutions across time horizons and risk appetites," said Raghav Iyengar, CEO, 360 ONE Asset. The 360 ONE Overnight Fund primarily invests in debt and money market instruments such as TREPs, reverse repos, treasury bills, certificates of deposit, and commercial papers—all with overnight maturities. It is suited for investors with a time horizon of one day to one month, who seek daily liquidity and reasonable returns over the short term without undue complexity. Also Read | Vishal Mega Mart, Tech Mahindra among stocks that HDFC Mutual Fund bought and sold in June With this successful fund raise, 360 ONE Asset further strengthens its position as a provider of innovative yet prudent fixed income solutions, tailored for the evolving needs of Indian investors. The fund is suitable for investors seeking regular income with high levels of safety and liquidity over short term and investment in debt and money market instruments with overnight maturity.